z-logo
open-access-imgOpen Access
Pembrolizumab (Keytruda)
Author(s) -
CADTH
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.474
Subject(s) - medicine , nephrectomy , renal cell carcinoma , pembrolizumab , adjuvant , systemic therapy , kidney cancer , cancer , oncology , adjuvant therapy , immunotherapy , surgery , kidney , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom